BenchSci
benchsci.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
BenchSci uses machine learning to read biomedical papers and extract which reagents and models were used in which experiments. Founded in 2015 in Toronto, its ASCEND platform helps preclinical scientists design experiments without repeating failed work. Most of the world's largest pharmaceutical companies use the product.
News
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
Read more
Report
BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity
Read more
Report
Rethinking the production and publication of machine-readable expressions of research findings
Scientific literature is the primary expression of scientific knowledge and an important source of research data. However, scientific knowledge expressed in narrative text documents is not inherently machine readable. To facilitate knowledge reuse, knowle
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.